WHO Child Obesity Guidelines 2026: When Are Medicines or Surgery Considered?
WHO’s first child and adolescent obesity guidelines draw a clear age line for medicines and surgery. See what is recommended, the evidence and national limits.
Health, science, environment, and everyday life news explained by Life Choice Note.
WHO’s first child and adolescent obesity guidelines draw a clear age line for medicines and surgery. See what is recommended, the evidence and national limits.
The FDA’s October 2026 ibogaine RFI is not an approval. Here is what it proposes for early OUD and PTSD trials, the safety risks, and the evidence limits.
What South Korea’s TB law amendment changes for workers with latent infection, when it takes effect, and which screening duties remain.
How the FDA-approved Autus pediatric pulmonary valve expands, what the 62-patient study found, and why long-term evidence still matters.
What WHO’s 2000–2023 estimates say about life expectancy, healthy life expectancy, NCDs, dementia and mental health—and what the figures cannot show.
KDCA’s Travel Health Alert service combines destination-specific disease, vaccination, quarantine and Q-CODE guidance. Here is what it covers and where its limits begin.
South Korea passed a new Vaccination Management Act. Here is when privately paid dose records may be integrated—and what does not change yet.
South Korea’s 2025 KNHANES estimated obesity prevalence at 49.1% among adult men and 59.0% among men in their 30s. Here is what the provisional survey can—and cannot—show.
WHO says reported cholera deaths rose 30% in 2025. Here is where the burden was concentrated, what the figures measure, and what they do not show.
WHO is expanding medical device prequalification to include AI-assisted TB chest X-ray screening. What the change means for diagnosis and national approvals.
WHO’s 2027 southern hemisphere flu vaccine composition explained, with the separate 2026–27 northern hemisphere and Korea vaccination context.